Akero Therapeutics Reports Encouraging 36-Week Analysis of 96-Week Phase 2b SYMMETRY Study, with a Trend on Fibrosis Improvement and Statistically Significant Results for NASH Resolution, Markers of Liver Injury and Fibrosis, Insulin Sensitization an – GlobeNewswire October 10, 2023
Biden takes victory lap on Inflation Reduction Act’s insulin cap, blames Republicans for not backing it October 9, 2022October 9, 2022
Scientists create insulin tablet that can be taken orally, replacing injections August 31, 2022August 31, 2022